Futu News, July 5th, announced on Tuesday. $CLOUDR (09955.HK)$Announcement: The company issues 19 million shares, priced at HK$30.50 per share, with 100 shares per board lot, expecting to be listed on July 6.
In the public offering stage, Zhiyun Health received a subscription of 7.89 times. The final number of shares allocated to the public offering was 1.9 million shares, accounting for approximately 10% of the total shares (before any exercise of over-allotment options). A total of 8629 valid applications were received, with a 50.00% allotment rate for one board lot.
In addition, the international offering has been oversubscribed, with the final number of shares issued being 17.1 million shares, equivalent to approximately 90% of the total shares issued (before any exercise of over-allotment options). Futu News has compiled the relevant data in the following table:
According to the prospectus,Wisdom Cloud Health provides medical supplies and SaaS products to hospitals and pharmacies, digital marketing services to pharmaceutical companies, online consultation and prescription issuance for patients, all centered around chronic disease management.Wisdom Cloud Health expects to continue generating the majority of its revenue by selling medical supplies to hospitals and pharmacies in the near future.
Wisdom Cloud Health aims to lead the digital chronic disease management market in China by providing solutions to all major participants in the medical value chain, including hospitals, pharmacies, pharmaceutical companies, patients, and doctors. According to a Frost & Sullivan report, based on the number of China hospital and pharmacy SaaS deployments as of December 31, 2021...